1312.HK

Tongfang Kontafarma Holdings Limited [1312.HK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

1312.HK Stock Summary

Top 10 Correlated Stocks

1312.HK

In the News

1312.HK Financial details

Company Rating
-
Market Cap
184.1M
Income
-19.64M
Revenue
1.47B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
720
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-1.83
Forward P/E
-
PEG
0.22
P/S
0.23
P/B
0.18
P/C
-
P/FCF
-3.74
Quick Ratio
0.28
Current Ratio
1.37
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-73.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-11.4%
Revenue Q/Q
-12.14%
EPS Q/Q
-274.29%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-5%
ROE
-10%
ROC
-0.03%
Gross Margin
57%
Oper. Margin
-5%
Profit Margin
-12%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.026-0.059
52W High
-
52W Low
-
RSI
58.23
Rel Volume
0.15
Avg Volume
852.31K
Volume
126K
Perf Week
21.74%
Perf Month
3.7%
Perf Quarter
-20%
Perf Half Y
-26.32%
-
-
-
-
Beta
0.043
-
-
Volatility
0%, 0%
Prev Close
7.69%
Price
0.028
Change
7.69%

Something similar

Top by Market Cap
VFINX
META
LLY.DE
ABEA.DE
VOO
Same Sector
CYCC
ECOR
GRPH
VNRX
QURE
Top Correlated Stocks
1750.HK
Similar Market Cap
BWFG
ALSEN.PA
SATHAISPAT.NS
WMPN
0MJH.L

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 852.31K
  • Market Capitalization 184.1M
  • Employee 720
  • CEO Mr. Chaowen Jiang
  • Headquarters Wan Chai,HK
  • IPO Date 2012-01-18
  • Website https://www.tfkf.com.hk

Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.